Nephrology focuses on diagnosing and treating kidney diseases. The kidneys filter waste, balance fluids, regulate blood pressure, and manage acute and chronic conditions.
Send us all your questions or requests, and our expert team will assist you.
Effective Treatment and Follow-up is the cornerstone of preserving kidney health in patients with diabetic nephropathy. This page is designed for international patients and their families who are seeking a clear, evidence‑based pathway from diagnosis through long‑term management at a JCI‑accredited facility. Did you know that diabetes accounts for nearly 40 % of end‑stage renal disease worldwide? Early intervention can dramatically slow progression and improve quality of life.
We will walk you through the therapeutic options available, the essential laboratory and imaging assessments, lifestyle adjustments that support kidney function, and how Liv Hospital coordinates a seamless follow‑up program for patients traveling from abroad. Whether you are preparing for your first appointment or looking to refine an existing care plan, the information below equips you with the knowledge to make informed decisions alongside your nephrology team.
Our comprehensive approach integrates cutting‑edge pharmacology, personalized nutrition, and continuous monitoring, ensuring that each step of the Treatment and Follow-up process aligns with international standards and the unique needs of patients from diverse backgrounds.
Diabetic nephropathy develops through a series of structural and functional changes in the kidneys. Recognizing these stages helps clinicians tailor Treatment and Follow-up strategies that target the underlying mechanisms rather than merely addressing symptoms.
Regular assessment of these markers allows physicians to intervene promptly. At Liv Hospital, we employ a standardized staging table to guide therapeutic decisions.
When diabetic nephropathy is detected at an early stage, the primary goal of Treatment and Follow-up is to halt or reverse kidney damage while maintaining overall metabolic health. The following therapeutic pillars are universally recommended.
These medications are initiated promptly after diagnosis and are adjusted during regular follow‑up visits based on laboratory feedback.
Test | Frequency (First Year) | Target Range
|
|---|---|---|
Serum Creatinine & eGFR | Every 3 months | Stable or slowly declining |
Urine Albumin‑Creatinine Ratio (UACR) | Every 3 months | Decrease or remain <30 mg/g |
HbA1c | Every 3 months | <7 % |
Blood Pressure | At each visit | <130/80 mmHg |
Consistent monitoring enables rapid medication titration, a critical component of successful Treatment and Follow-up. Liv Hospital’s international patient coordinators arrange lab draws at partner facilities worldwide, ensuring continuity of data even when patients are traveling.
When early measures are insufficient and kidney function begins to decline, more intensive Treatment and Follow-up is required. The following modalities have demonstrated efficacy in slowing progression and reducing cardiovascular events.
For patients approaching end‑stage renal disease (ESRD), proactive planning is essential. Liv Hospital provides a multidisciplinary pathway that includes:
While not a substitute for evidence‑based medicine, adjunctive approaches such as low‑protein diet plans, structured exercise programs, and stress‑reduction techniques are incorporated into the overall Treatment and Follow-up regimen to enhance patient resilience.
Accurate and timely assessment of renal biomarkers is the backbone of any Treatment and Follow-up program. The following tests are routinely ordered, with interpretation guidelines that help clinicians adjust therapy.
Test | Purpose | Frequency
|
|---|---|---|
Renal Ultrasound | Assess kidney size, cysts, and obstruction | Every 1‑2 years or if clinical change |
Kidney MRI (optional) | Detailed parenchymal evaluation | When ultrasound inconclusive |
Cardiovascular Risk Assessment | Coronary calcium scoring or stress test | Every 3‑5 years |
Liv Hospital’s International Care Team coordinates these investigations across borders, uploading results to a secure cloud portal that your nephrologist can access instantly, preserving the continuity of Treatment and Follow-up regardless of location.
Medical therapy alone cannot fully prevent kidney decline; patient‑driven lifestyle changes are integral to a successful Treatment and Follow-up plan. Education is delivered in the patient’s preferred language by certified diabetes educators and dietitians.
Regular aerobic exercise (150 minutes/week) improves insulin sensitivity, reduces blood pressure, and supports cardiovascular health—key factors influencing renal outcomes.
Both smoking and excessive alcohol accelerate renal injury. Structured cessation programs and counseling are offered as part of the comprehensive Treatment and Follow-up package.
For international patients, seamless coordination between home‑country providers and Liv Hospital is vital. Our dedicated International Patient Services (IPS) team ensures that every step of the Treatment and Follow-up journey is organized, transparent, and patient‑centric.
Our integrated electronic health record (EHR) system links your home physician to our specialists, allowing real‑time updates on medication changes, test results, and any adverse events. This continuity is the hallmark of effective Treatment and Follow-up for diabetic nephropathy patients traveling from abroad.
Liv Hospital Vadistanbul
Prof. MD. Süleyman Tevfik Ecder
Nephrology
Liv Hospital Bahçeşehir
Asst. Prof. MD. Himmet Bora Uslu
Nephrology
Liv Hospital Bahçeşehir
Prof. MD. Mehmet Taşdemir
Pediatric Nephrology
Liv Hospital Bahçeşehir
Prof. MD. Ozan Özkaya
Pediatric Nephrology
Liv Hospital Ankara
Prof. MD. Hüsnü Oğuz Söylemezoğlu
Pediatric Nephrology
Liv Bona Dea Hospital Bakü
MD. FERHAD ŞİRİNOV
Nephrology
Send us all your questions or requests, and our expert team will assist you.
Diabetic nephropathy often begins with a hyperfiltration phase where the glomerular filtration rate (GFR) is elevated, sometimes before any symptoms appear. The first measurable laboratory sign is microalbuminuria, where small amounts of albumin appear in the urine, indicating early endothelial damage. Patients may also experience mild hypertension or a gradual decline in eGFR. Detecting these changes through regular screening allows clinicians to start renin‑angiotensin‑aldosterone system (RAAS) blockade and tighter glycemic control, which can slow disease progression.
For patients in the early stages, the cornerstone of therapy includes RAAS blockade with an ACE inhibitor or an ARB to reduce intraglomerular pressure and proteinuria. Tight glycemic control (HbA1c < 7 %) using insulin analogues or modern oral agents is essential to limit further kidney damage. Blood pressure should be kept below 130/80 mmHg, often requiring a combination of antihypertensives. Statins are added to lower cardiovascular risk, which is a major driver of renal decline. These medications are initiated promptly after diagnosis and titrated based on quarterly lab results.
SGLT2 inhibitors, originally developed for glucose control, have been shown to lower intraglomerular pressure by reducing sodium reabsorption in the proximal tubule, which in turn diminishes hyperfiltration. Clinical trials demonstrate that they slow eGFR decline, reduce albuminuria, and lower the risk of cardiovascular events, even in patients with relatively good glycemic control. Because of these benefits, they are now recommended as part of the therapeutic arsenal for patients whose disease has progressed beyond the early stage.
Nutrition and activity play a pivotal role. Patients are advised to limit protein to about 0.8 g/kg/day in CKD stages 3‑4, keep sodium under 2 g/day, and adjust potassium based on serum levels and medication use. A diet rich in low‑glycemic index carbohydrates, fiber, and healthy fats helps maintain stable blood glucose. Regular aerobic exercise (≈150 minutes/week) improves insulin sensitivity and blood pressure. Smoking cessation and limiting alcohol are essential, as both accelerate renal injury. Liv Hospital provides dietitian‑led counseling and structured exercise programs tailored to each patient.
Liv Hospital’s International Patient Services (IPS) team creates a seamless pathway: a pre‑admission virtual nephrology consult reviews medical history and travel logistics; a written personalized care plan outlines appointments, lab dates, and medication adjustments; multilingual interpreters and companion services are available during the hospital stay; post‑discharge tele‑monitoring includes weekly video calls, remote blood‑pressure cuffs, and secure lab result uploads. The team also assists with visas, airport transfers, and local accommodation, ensuring continuity of care across borders.
BlogDiabetic NephropathyMar 03, 2026Discover the top diabetes-friendly foods that can help lower blood sugar fast. Fiber-rich whole grains, non...
BlogDiabetic NephropathyMar 03, 2026Optimize your diet for diabetes management. Learn 7 proven nutrition strategies to lower HbA1c, boost insul...
BlogDiabetic NephropathyMar 03, 2026Understand the growing global burden of DKD, the leading cause of chronic kidney disease affecting 20-40% o...
BlogDiabetic NephropathyMar 03, 2026Protect kidney health with diabetic nephropathy screening. Catch microalbuminuria early and manage diabetes...
BlogDiabetic NephropathyMar 03, 2026Comprehensive nephropathy screening is crucial for diabetes patients - explore the 5 essential CKD tests to...
BlogDiabetic NephropathyMar 03, 2026Understand the impact of diabetes on bladder control. Our article examines the prevalence of urinary freque...
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 174 28 17